About the Authors

Tomoaki Higashiyama

higashi@belle.shiga-med.ac.jp

Affiliation Department of Ophthalmology, Shiga University of Medical Science, Otsu, Japan

Yasuhiro Nishida

Affiliation Clinical Medical Education Center, Shiga University of Medical Science, Otsu, Japan

Masahito Ohji

Affiliation Department of Ophthalmology, Shiga University of Medical Science, Otsu, Japan

Competing Interests

I have read the journal's policy and the authors of this manuscript have the following competing interests: Higashiyama: Senju Pharmaceutical: Lecture Fee, Pfizer Japan: Lecture Fee. Nishida: None. Ohji: Alcon Japan: Consultant, Lecture Fee, Novartis Pharmaceutical Company: Consultant, Lecture Fee, Santen Pharmaceutical Company: Consultant, Lecture Fee, Bayer: Consultant, Lecture Fee, Shionogi & CO.: Consultant, Lecture Fee, Pfizer Japan: Consultant, Sanwa Kagaku Institute: Consultant, Carl Zeiss Japan: Lecture Fee, Otsuka Pharmaceutical Company: Lecture Fee, MSD: Lecture, and Kowa Pharmaceutical Company: Lecture Fee. This does not alter our adherence to PLOS ONE policies on sharing data and materials.

Author Contributions

Conceptualization: TH YN MO. Data curation: TH. Formal analysis: TH YN MO. Investigation: TH YN MO. Methodology: TH YN MO. Project administration: TH. Resources: TH YN MO. Software: TH. Supervision: MO. Validation: TH. Visualization: TH YN MO. Writing – original draft: TH. Writing – review & editing: YN MO.